Outset Medical (OM) to Release Earnings on Wednesday

Outset Medical (NASDAQ:OM - Get Free Report) is set to issue its quarterly earnings data after the market closes on Wednesday, May 8th. Analysts expect the company to announce earnings of ($0.60) per share for the quarter. Parties interested in listening to the company's conference call can do so using this link.

Outset Medical (NASDAQ:OM - Get Free Report) last issued its quarterly earnings data on Wednesday, February 21st. The company reported ($0.77) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.74) by ($0.03). The company had revenue of $30.51 million during the quarter, compared to analysts' expectations of $30.40 million. Outset Medical had a negative net margin of 132.54% and a negative return on equity of 102.50%. On average, analysts expect Outset Medical to post $-2 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

Outset Medical Trading Up 12.6 %

Outset Medical stock traded up $0.32 during trading on Wednesday, hitting $2.85. The company's stock had a trading volume of 962,690 shares, compared to its average volume of 1,013,196. The stock has a market capitalization of $147.35 million, a price-to-earnings ratio of -0.77 and a beta of 1.99. The stock's fifty day moving average is $2.51 and its 200 day moving average is $3.78. Outset Medical has a 1-year low of $1.92 and a 1-year high of $24.13. The company has a debt-to-equity ratio of 1.06, a quick ratio of 4.37 and a current ratio of 5.26.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on the company. CL King upgraded Outset Medical from a "neutral" rating to a "buy" rating and set a $6.00 target price for the company in a research note on Friday, April 5th. BTIG Research assumed coverage on Outset Medical in a research note on Monday, April 8th. They issued a "buy" rating and a $6.00 target price for the company. Finally, Royal Bank of Canada lowered Outset Medical from an "outperform" rating to a "sector perform" rating and dropped their target price for the company from $14.00 to $6.00 in a research note on Friday, January 12th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and three have assigned a buy rating to the company's stock. Based on data from MarketBeat, Outset Medical has a consensus rating of "Hold" and an average target price of $5.42.

About Outset Medical

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.